CI

At a glance

ClinicalIndex Comparison Record
Early Ph 1Completed· 20 enrolled
Drug / intervention
Pharmacy-based methadone administration and dispensingdrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04308694
NCT04308694Early Ph 1Completed
CompareCT.gov

A Pilot Study to Permit Opioid Treatment Program Physicians to Prescribe Methadone Through Community Pharmacies for Their Stable Methadone Patients

Friends Research Institute, Inc.·interventional·Posted Mar 16, 2020·Updated Apr 1, 2022

In Brief

A Early Phase 1 clinical trial evaluating Pharmacy-based methadone administration and dispensing for Opioid-use Disorder. Completed, enrolled 20 participants across 3 sites.

Detailed Summary

The overarching goal of this pilot study is to explore the feasibility, acceptability, and patient/provider satisfaction of pharmacy-based administration and dispensing of methadone for opioid use disorder. The results gained will inform the development of a future multisite randomized clinical trial.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOpioid-use Disorder
CountriesUnited States
CollaboratorsDuke Health, National Institute on Drug Abuse (NIDA)

Timeline

Early Ph 1CompletedFinished
202120222023202420252026
First PostedMar 16, 2020
Enrollment StartAug 6, 2020
Primary CompletionJan 5, 2021
Study CompletionJan 18, 2021
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 6.3 years ago

Interventions

Pharmacy-based methadone administration and dispensingdrug

Eligible participants receiving between 6- and 13-days of methadone take-home doses will have methadone administration and dispensing transferred from the opioid treatment program to the partnered community pharmacy. Each participant will be assessed monthly for 3 months (at 1, 2, and 3 months following intake/baseline) to explore the feasibility of transferring their methadone administration and dispensing to the select community pharmacy.